We are live on
!
Find out more
FRA
Front Row Advisors Portfolio holdings
AUM
$296M
1-Year Est. Return
34.73%
This Fund
S&P 500
This Quarter
Est. Return
+11.38%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$225M
AUM Growth
+$16.4M
(+7.8%)
Cap. Flow
-$3.11M
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
37.76%
Holding
984
New
21
Increased
118
Reduced
237
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$99K |
| 2 |
Global X NASDAQ-100 Covered Call ETF
QYLD
|
+$81.3K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$71.3K |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$54.4K |
| 5 |
Intuitive Surgical
ISRG
|
+$53.3K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$817K |
| 2 |
NVIDIA
NVDA
|
+$217K |
| 3 |
MRSH
Marsh
MRSH
|
+$145K |
| 4 |
Fortinet
FTNT
|
+$143K |
| 5 |
Broadcom
AVGO
|
+$143K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.58% |
| 2 | Healthcare | 11.76% |
| 3 | Financials | 6.86% |
| 4 | Consumer Staples | 6.86% |
| 5 | Consumer Discretionary | 5.43% |
Similar funds
SM
RHP
MSWM
RLIM
JCM
CA
KNFPWM
NRC
Front Row Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Front Row Advisors held 984 positions worth $225M, up 7.8% from $208M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Front Row Advisors's Q2 2023 filing shows 21 new, 118 increased, 237 reduced and 53 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 635 shares worth $31K. The largest sale was Medtronic, an estimated $817K.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 38% a quarter earlier, followed by Healthcare and Financials.
- Front Row Advisors's largest Q2 2023 buy was JPMorgan Nasdaq Equity Premium Income ETF: 635 shares worth $31K.
- Front Row Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $99K increase.
- Front Row Advisors's biggest Q2 2023 reduction was Medtronic, cutting an estimated $817K.
- Front Row Advisors fully exited ProShares UltraShort S&P500 in Q2 2023, selling an estimated $97K.
- Front Row Advisors's ten largest holdings make up 38% of its $225M portfolio in Q2 2023.
- Front Row Advisors opened 21 new positions and closed 53 in Q2 2023.
- Front Row Advisors's portfolio value rose 7.8% quarter-over-quarter to $225M.
Based on Front Row Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.